PubRank

Kenneth E Sherman

Author PubWeight™ 87.76‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons. N Engl J Med 2004 7.67
2 Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection. Liver Transpl 2012 4.65
3 Hepatitis C virus infection in USA: an estimate of true prevalence. Liver Int 2011 3.36
4 Combination therapy with telaprevir for chronic hepatitis C virus genotype 1 infection in patients with HIV: a randomized trial. Ann Intern Med 2013 2.25
5 Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1. N Engl J Med 2015 1.94
6 End-stage liver disease in persons with hemophilia and transfusion-associated infections. Blood 2002 1.73
7 Immune recovery is associated with persistent rise in hepatitis C virus RNA, infrequent liver test flares, and is not impaired by hepatitis C virus in co-infected subjects. AIDS 2002 1.69
8 Occult hepatitis B in HIV-infected patients. J Acquir Immune Defic Syndr 2004 1.65
9 GB virus C (GBV-C) infection in hepatitis C virus (HCV)/HIV-coinfected patients receiving HCV treatment: importance of the GBV-C genotype. J Infect Dis 2006 1.64
10 Evolution of treatment-emergent resistant variants in telaprevir phase 3 clinical trials. Clin Infect Dis 2013 1.62
11 The clinical and physiological spectrum of interferon-alpha induced thyroiditis: toward a new classification. Hepatology 2006 1.49
12 Extrahepatic replication of HCV: insights into clinical manifestations and biological consequences. Hepatology 2006 1.38
13 HIV mono-infection is associated with FIB-4 - A noninvasive index of liver fibrosis - in women. Clin Infect Dis 2011 1.37
14 Serum bilirubin levels in the U.S. population: gender effect and inverse correlation with colorectal cancer. Hepatology 2004 1.36
15 Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127. Hepatology 2006 1.32
16 HIV/hepatitis C coinfection natural history and disease progression. Curr Opin HIV AIDS 2011 1.23
17 The prevalence and significance of occult hepatitis B virus in a prospective cohort of HIV-infected patients. J Acquir Immune Defic Syndr 2007 1.22
18 Comparison of HCV-specific intrahepatic CD4+ T cells in HIV/HCV versus HCV. Hepatology 2004 1.19
19 Hepatitis C viral evolution in genotype 1 treatment-naïve and treatment-experienced patients receiving telaprevir-based therapy in clinical trials. PLoS One 2012 1.19
20 The cost-effectiveness of screening for chronic hepatitis B infection in the United States. Clin Infect Dis 2011 1.17
21 Acute hepatitis C virus infection: a chronic problem. Hepatology 2008 1.15
22 Hepatitis C virus (HCV) diversity in HIV-HCV-coinfected subjects initiating highly active antiretroviral therapy. J Infect Dis 2004 1.14
23 Hepatitis C virus (HCV)-specific CD8+ cells produce transforming growth factor beta that can suppress HCV-specific T-cell responses. J Virol 2007 1.13
24 Recurrent bleeding from peptic ulcer associated with adherent clot: a randomized study comparing endoscopic treatment with medical therapy. Gastrointest Endosc 2002 1.11
25 HCV quasispecies evolution: association with progression to end-stage liver disease in hemophiliacs infected with HCV or HCV/HIV. Blood 2004 1.08
26 Clinical application of polymerase chain reaction to diagnose Clostridium difficile in hospitalized patients with diarrhea. Clin Gastroenterol Hepatol 2004 1.07
27 HCV kinetics, quasispecies, and clearance in treated HCV-infected and HCV/HIV-1-coinfected patients with hemophilia. Hepatology 2006 1.07
28 Occult hepatitis B: clinical implications and treatment decisions. Dig Dis Sci 2010 1.06
29 Incident hepatitis C virus infection among US HIV-infected men enrolled in clinical trials. Clin Infect Dis 2011 1.04
30 Health values of patients coinfected with HIV/hepatitis C: are two viruses worse than one? Med Care 2006 1.02
31 Cost-effectiveness of screening for chronic hepatitis C infection in the United States. Clin Infect Dis 2013 1.00
32 Efficacy of inactivated hepatitis A vaccine in HIV-infected patients: a hierarchical bayesian meta-analysis. Vaccine 2005 0.98
33 Nucleoside analogues and mitochondrial toxicity. Clin Infect Dis 2004 0.98
34 Hepatitis C virus coinfection and superinfection. J Infect Dis 2007 0.97
35 The changing epidemiology of liver disease in HIV patients. AIDS Rev 2013 0.94
36 CD8+ cell responses to hepatitis C virus (HCV) in the liver of persons with HCV-HIV coinfection versus HCV monoinfection. J Infect Dis 2005 0.94
37 Hepatitis C and HIV co-infection: new drugs in practice and in the pipeline. Curr HIV/AIDS Rep 2012 0.94
38 Provisional guidance on the use of hepatitis C virus protease inhibitors for treatment of hepatitis C in HIV-infected persons. Clin Infect Dis 2012 0.93
39 IL28B alleles exert an additive dose effect when applied to HCV-HIV coinfected persons undergoing peginterferon and ribavirin therapy. PLoS One 2011 0.89
40 Antigen-specific immune responses and liver histology in HIV and hepatitis C coinfection. AIDS 2005 0.89
41 Therapy for hepatitis C virus infection increases survival of patients with pretreatment anemia. Clin Gastroenterol Hepatol 2013 0.88
42 Management of HBV/HIV-coinfected Patients. Semin Liver Dis 2005 0.88
43 Hepatitis E virus antibodies in patients with chronic liver disease. Emerg Infect Dis 2009 0.88
44 Screening for hepatitis C virus non-nucleotide resistance mutations in treatment-naive women. J Antimicrob Chemother 2009 0.88
45 Improving noninvasive methods of assessing liver fibrosis in patients with hepatitis C virus/human immunodeficiency virus co-infection. Clin Gastroenterol Hepatol 2008 0.87
46 Challenges and opportunities for hepatitis C drug development in HIV-hepatitis C virus-co-infected patients. AIDS 2011 0.87
47 Genotypic characterization of symptomatic hepatitis E virus (HEV) infections in Egypt. J Clin Virol 2009 0.87
48 Extended therapy with pegylated interferon and weight-based ribavirin for HCV-HIV coinfected patients. HIV Clin Trials 2012 0.86
49 Effects of HCV treatment on cytokine expression during HCV/HIV coinfection. J Interferon Cytokine Res 2006 0.86
50 Cytokine expression during chronic versus occult hepatitis B virus infection in HIV co-infected individuals. Cytokine 2009 0.85
51 Hepatitis C-related arthropathy: Diagnostic and treatment considerations. J Musculoskelet Med 2010 0.84
52 Viral factors associated with cytokine expression during HCV/HIV co-infection. J Interferon Cytokine Res 2007 0.83
53 Prevalence of mutations in hepatitis C virus core protein associated with alteration of NF-kappaB activation. Virus Res 2006 0.83
54 Impact of peginterferon alpha and ribavirin treatment on lipid profiles and insulin resistance in Hepatitis C virus/HIV-coinfected persons: the AIDS Clinical Trials Group A5178 Study. Clin Infect Dis 2012 0.83
55 Extrahepatic manifestations of hepatitis C infection: navigating CHASM. Curr HIV/AIDS Rep 2015 0.82
56 Use of a standardized patient exercise to assess core competencies during fellowship training. J Grad Med Educ 2010 0.82
57 Treatment of HBV/HCV coinfection: releasing the enemy within. Gastroenterology 2008 0.81
58 Low-level HIV infection of hepatocytes. Virol J 2012 0.81
59 Treatment of hepatitis C virus/HIV coinfection. Clin Liver Dis 2005 0.80
60 Protective role of humoral immune responses during an outbreak of hepatitis E in Egypt. Trans R Soc Trop Med Hyg 2012 0.79
61 Immune activation in HIV/HCV-infected patients is associated with low-level expression of liver expressed antimicrobial peptide-2 (LEAP-2). J Clin Pathol 2013 0.79
62 Liver transplantation trends in the HIV population. Dig Dis Sci 2011 0.79
63 Relationships between cellular immune responses and treatment outcomes with interferon and ribavirin in HIV/hepatitis C virus co-infection. AIDS 2006 0.79
64 Complexity and diversity of hepatitis C virus RNA in african americans and whites: analysis of the envelope-coding domain. J Infect Dis 2004 0.79
65 Epigenetic modification of FOXP3 in patients with chronic HIV infection. J Acquir Immune Defic Syndr 2014 0.79
66 Variability of the polymerase gene (NS5B) in hepatitis C virus-infected women. J Clin Microbiol 2010 0.79
67 Evidence of distinct populations of hepatitis C virus in the liver and plasma of patients co-infected with HIV and HCV. J Med Virol 2014 0.78
68 Analysis of a non-structural gene reveals evidence of possible hepatitis C virus (HCV) compartmentalization. J Med Virol 2012 0.77
69 HIV variability in the liver and evidence of possible compartmentalization. AIDS Res Hum Retroviruses 2011 0.77
70 Brief Report: CD14brightCD16- monocytes and sCD14 level negatively associate with CD4-memory T-cell frequency and predict HCV-decline on therapy. J Acquir Immune Defic Syndr 2016 0.76
71 Clinical trials of treatment for hepatitis C virus infection in HIV-infected patients: past, present, and future. Clin Infect Dis 2005 0.76
72 Hepatitis delta and HIV infection. AIDS 2017 0.76
73 Characterization of HCV NS3 Protease Variants in HCV/HIV Coinfected Patients by Ultra-deep Sequence Analysis: Relationship to Hepatic Fibrosis. J Acquir Immune Defic Syndr 2016 0.75
74 What is the impact of HIV infection on survival after liver transplantation? Nat Clin Pract Gastroenterol Hepatol 2008 0.75
75 Beyond interferon for hepatitis C: living in the present while hoping for the future. Gastroenterology 2004 0.75
76 Intrafamilial transmission of hepatitis C virus in patients with hepatitis C and human immunodeficiency virus coinfection. Am J Gastroenterol 2003 0.75
77 Correlation of single photon emission computed tomography parameters as a noninvasive alternative to liver biopsies in assessing liver involvement in the setting of HIV and hepatitis C virus coinfection: a multicenter trial of the Adult AIDS Clinical Trials Group. J Acquir Immune Defic Syndr 2003 0.75
78 Pilot study of low-dose interleukin-2, pegylated interferon-alpha 2b, and ribavirin for the treatment of hepatitis C virus infection in patients with HIV infection. J Infect Dis 2005 0.75